Gansulog Adverse Reactions

Has primarily symptoms of hypoglycemia.
Cardiovascular: Hypertension, peripheral edema, retinal vascular disease, thrombophlebitis, traumatic haematoma.
Central nervous system: Depression, headache.
Endocrine & metabolic: Hypoglycemia (more common in Type I on combination regimens), sodium retention.
Gastrointestinal: Diarrhea, Nausea, Vomiting, Toothache.
Genitourinary: Urinary tract infection.
Immunologic: Antibody development (effect on therapy not reported).
Infection: Infection, influenza.
Local: Erythema at injection site, itching at injection site, localized edema, pain at injection site, swelling at injection site, extravasation, phlebitis.
Neuromuscular & skeletal: Arthralgia, back pain, limb pain.
Ophthalmic: Cataract retinopathy.
Respiratory: Bronchitis, cough, nasopharyngitis, pharyngitis (children & adolescents), rhinitis (children & adolescents), sinusitis, upper respiratory tract infection (more common in adults), oropharyngeal pain.
Miscellaneous: Accidental injury, chest pain.
Rare but important or life-threatening: Hyperglycemia, hypersensitivity reaction, hypertrophy at injection site, injection site reaction (including urticaria and inflammation), lipoatrophy at injection site, skin rash, weight gain.
Skin and subcutaneous tissue disorders: Frequency 'not known': Cutaneous amyloidosis.
Skin and subcutaneous tissue disorders: Lipodystrophy and cutaneous amyloidosis may occur at the injection site and delay local insulin absorption. Continuous rotation of the injection site within the given injection area may help to reduce or prevent these reactions.